Solventum Corporation (SOLV) Tuesday said that it has completed the sale of its Purification & Filtration business to Thermo Fisher Scientific Inc. (TMO) for $4 billion in cash.
As previously announced, the company plans to use the net proceeds of $3.4 billion primarily to pay down debts.
Additionally, Solventum has updated its full-year outlook to reflect the partial year increase of the accelerated divestiture of Purification & Filtration business.
Solventum currently expects adjusted EPS to be in the range of $5.88 - $6.03, up from the previous outlook of $5.80 - $5.95.
Analysts on average expect the company to report earnings of $5.88 per share for the year. Analysts' estimates typically exclude special items.
The company continues to expect organic sales growth of 2%-3%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.